ReviewBiomedicines2022

MmpL3 Inhibition as a Promising Approach to Develop Novel Therapies against Tuberculosis: A Spotlight on SQ109, Clinical Studies, and Patents Literature.

Mohd Imran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.